Literature DB >> 24030943

Reduced insulin sensitivity in adults with pseudohypoparathyroidism type 1a.

Ranganath Muniyappa1, Mary A Warren, Xiongce Zhao, Sara C Aney, Amber B Courville, Kong Y Chen, Robert J Brychta, Emily L Germain-Lee, Lee S Weinstein, Monica C Skarulis.   

Abstract

CONTEXT: Disruption of the Gsα maternal allele leads to severe obesity and insulin resistance in mice and early-onset obesity in patients with pseudohypoparathyroidism (PHP) type 1a. However, insulin resistance and glucose metabolism have not been systematically characterized in patients with PHP1a. OBJECTIVE, DESIGN, AND
SETTING: In a cross-sectional, case-control study, we examined insulin sensitivity, β-cell function, energy expenditure (EE), and sympathetic nervous system activity in adults with PHP1a. STUDY PARTICIPANTS: PHP1a patients (n = 8) and healthy control subjects (n = 24) matched for age (41 ± 7 vs 41 ± 7 years [mean ± SD]), gender, and percent body fat.
METHODS: Insulin sensitivity (SI), acute insulin response to glucose, and disposition index were assessed during a frequently sampled iv glucose tolerance test. Oral glucose insulin sensitivity (OGIS) was measured during a mixed meal. EE was measured using whole-room indirect calorimetry. Body composition was assessed via dual-energy x-ray absorptiometry and sympathetic nervous system activity by measuring 24-hour urinary catecholamine concentrations.
RESULTS: PHP1a patients were less insulin-sensitive than their matched controls based upon SI and OGIS. Nondiabetic PHP1a patients tended to have a lower SI (P = .09) and reduced OGIS (P = .03). Disposition index, a composite measure of β-cell function, also tended to be lower in patients (P = .07). Total caloric intake, resting EE, total EE, meal-induced thermogenesis, and 24-hour urinary catecholamine concentrations were not significantly different between the groups.
CONCLUSIONS: Adults with PHP-1a have reduced insulin sensitivity compared with their matched controls that may contribute to the pathogenesis of glucose intolerance and diabetes in these patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24030943      PMCID: PMC3816268          DOI: 10.1210/jc.2013-1594

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Alternative Gnas gene products have opposite effects on glucose and lipid metabolism.

Authors:  Min Chen; Oksana Gavrilova; Jie Liu; Tao Xie; Chuxia Deng; Annie T Nguyen; Lisa M Nackers; Javier Lorenzo; Laura Shen; Lee S Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

2.  Resistance to the lipolytic action of epinephrine: a new feature of protein Gs deficiency.

Authors:  J C Carel; C Le Stunff; L Condamine; E Mallet; J L Chaussain; P Adnot; M Garabédian; P Bougnères
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

Review 3.  Genetic diseases associated with heterotrimeric G proteins.

Authors:  Lee S Weinstein; Min Chen; Tao Xie; Jie Liu
Journal:  Trends Pharmacol Sci       Date:  2006-04-05       Impact factor: 14.819

Review 4.  Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.

Authors:  L S Weinstein; S Yu; D R Warner; J Liu
Journal:  Endocr Rev       Date:  2001-10       Impact factor: 19.871

5.  Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity.

Authors:  Dominique N Long; Sarah McGuire; Michael A Levine; Lee S Weinstein; Emily L Germain-Lee
Journal:  J Clin Endocrinol Metab       Date:  2006-12-12       Impact factor: 5.958

6.  Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene.

Authors:  Giovanna Mantovani; Mohamad Maghnie; Giovanna Weber; Ernesto De Menis; Valeria Brunelli; Marco Cappa; Paola Loli; Paolo Beck-Peccoz; Anna Spada
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

7.  Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance.

Authors:  Emily L Germain-Lee; Joshua Groman; Janet L Crane; Suzanne M Jan de Beur; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

8.  Classical and model-based estimates of beta-cell function during a mixed meal vs. an OGTT in a population-based cohort.

Authors:  Josina M Rijkelijkhuizen; Cynthia J Girman; Andrea Mari; Marjan Alssema; Thomas Rhodes; Giel Nijpels; Piet J Kostense; Peter P Stein; Elisabeth M Eekhoff; Robert J Heine; Jacqueline M Dekker
Journal:  Diabetes Res Clin Pract       Date:  2008-12-20       Impact factor: 5.602

9.  Beta cell-specific deficiency of the stimulatory G protein alpha-subunit Gsalpha leads to reduced beta cell mass and insulin-deficient diabetes.

Authors:  Tao Xie; Min Chen; Qing-Hong Zhang; Zheng Ma; Lee S Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-20       Impact factor: 11.205

10.  Energy expenditure in obese children with pseudohypoparathyroidism type 1a.

Authors:  A H Shoemaker; J P Lomenick; B R Saville; W Wang; M S Buchowski; R D Cone
Journal:  Int J Obes (Lond)       Date:  2012-12-11       Impact factor: 5.095

View more
  18 in total

1.  The stimulatory G protein Gsα is required in melanocortin 4 receptor-expressing cells for normal energy balance, thermogenesis, and glucose metabolism.

Authors:  Brandon Podyma; Hui Sun; Eric A Wilson; Bradley Carlson; Ethan Pritikin; Oksana Gavrilova; Lee S Weinstein; Min Chen
Journal:  J Biol Chem       Date:  2018-05-24       Impact factor: 5.157

Review 2.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

3.  Increased Prevalence of Sleep Apnea in Children with Pseudohypoparathyroidism Type 1a.

Authors:  Hannah Landreth; Beth A Malow; Ashley H Shoemaker
Journal:  Horm Res Paediatr       Date:  2015-04-23       Impact factor: 2.852

Review 4.  Nonclassic features of pseudohypoparathyroidism type 1A.

Authors:  Ashley H Shoemaker; Harald Jüppner
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-02       Impact factor: 3.243

5.  Mice maintain predominantly maternal Gαs expression throughout life in brown fat tissue (BAT), but not other tissues.

Authors:  Olta Tafaj; Steven Hann; Ugur Ayturk; Matthew L Warman; Harald Jüppner
Journal:  Bone       Date:  2017-07-08       Impact factor: 4.398

6.  Gsα deficiency in the dorsomedial hypothalamus underlies obesity associated with Gsα mutations.

Authors:  Min Chen; Yogendra B Shrestha; Brandon Podyma; Zhenzhong Cui; Benedetta Naglieri; Hui Sun; Thuy Ho; Eric A Wilson; Yong-Qi Li; Oksana Gavrilova; Lee S Weinstein
Journal:  J Clin Invest       Date:  2016-12-19       Impact factor: 14.808

7.  Obstructive Sleep Apnea and Otolaryngologic Manifestations in Children with Pseudohypoparathyroidism.

Authors:  Kathleen L Curley; Sachini Kahanda; Katia M Perez; Beth A Malow; Ashley H Shoemaker
Journal:  Horm Res Paediatr       Date:  2018-02-16       Impact factor: 2.852

8.  Glucose Homeostasis and Energy Balance in Children With Pseudohypoparathyroidism.

Authors:  Katia M Perez; Kathleen L Curley; James C Slaughter; Ashley H Shoemaker
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

9.  Resting Energy Expenditure Is Decreased in Pseudohypoparathyroidism Type 1A.

Authors:  Jeffrey D Roizen; Jennifer Danzig; Veronique Groleau; Shana McCormack; Alex Casella; Jennifer Harrington; Etienne Sochett; Andrew Tershakovec; Babette S Zemel; Virginia A Stallings; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2015-12-28       Impact factor: 5.958

10.  Gsα Deficiency in the Ventromedial Hypothalamus Enhances Leptin Sensitivity and Improves Glucose Homeostasis in Mice on a High-Fat Diet.

Authors:  Alta Berger; Ahmed Kablan; Catherine Yao; Thuy Ho; Brandon Podyma; Lee S Weinstein; Min Chen
Journal:  Endocrinology       Date:  2015-12-15       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.